Ibrahim Turkoz

10PUBLICATIONS
16CO-AUTHORS
Nanotoxicology, health and safetyPharmaceutical delivery technologiesPharmacogenomicsClinical pharmacy and pharmacy practiceBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 09, 2026
Efficacy and Safety of Nipocalimab in Adults With Generalised Myasthenia Gravis: An Asian Subgroup Analysis of the Vivacity-MG3 Study.

|Jun 23, 2025
Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis.

Joshua M Hamilton, Karen L Johnston, James Simples Jnr

|Nov 28, 2024
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Once-Monthly versus Oral Antipsychotics in Patients with Schizophrenia: An Integrated Patient-Level Meta Analysis of the PROSIPAL and PRIDE Studies.

Martha Sajatovic, Monica Doring, Oliver J Lopena

|Jul 23, 2024
Up-front matching: an ongoing recruitment method for prospective observational studies that mimics randomization for selected baseline covariates.

William H Olson, Ibrahim Turkoz

|Oct 03, 2023
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia.

Ibrahim Turkoz, Joshua Wong, Benjamin Chee

|Sep 06, 2022
Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections.

Ibrahim Turkoz, Mehmet Daskiran, H Lynn Starr

Pageof 2

Frequent Collaborators

2 joint publications

Srihari Gopal

1 joint publications

Madhukar H Trivedi

1 joint publications

Edward Kim

1 joint publications

Stephane Borentain